/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported.
/PRNewswire/ The "US Bispecific Antibodies Market & Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com s offering. The.
/PRNewswire/ Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported.
CAMBRIDGE, Mass., July 12, 2023 /PRNewswire/ Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that, based on the.